Serum Insulin-Like Growth Factor-1 Levels Predict Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Antiangiogenic Therapy
published in: Clinical Cancer Research
date of publication: 2012-05-23
language: English
main subject: preproinsulin, angiogenesis inhibitor, hepatocellular carcinoma
Cites articles
There is nothing here
Article - wd:Q58215170